NC Cancer Inequities & Policy Initiative

An independent research program linking social determinants of health to cancer outcomes in North Carolina, culminating in an evidence-based state policy proposal.


Additional Work

Policy analysis, bioethical argument, and engineering research across computational biology, health systems, and clinical technology.

The Ethical Necessity of Rejecting the American Healthcare System

PHI 325: Bio-Medical Ethics • NC State University • April 2026

Constructs a convergence argument across six ethical frameworks — relational, virtue, deontological, pluralist, liberal egalitarian, and utilitarian — to demonstrate that the American healthcare system is not merely imperfect but ethically indefensible. Grounded in empirical SDOH data including a 9.9-year life expectancy gap between the most and least advantaged Americans and a 58% cancer mortality disparity between high- and low-income counties. Engages primary sources in Gilligan, Noddings, Kant, Ross, Rawls, and Mill alongside secondary works by Mbembe, Roberts, Harding, and Daniels.

Bioethics Health Equity SDOH Policy

Telehealth Coverage for the Publicly Insured in North Carolina

PS 310: Public Policy • NC State University • November 2025

Comprehensive policy analysis evaluating three alternative approaches to sustaining telehealth access for Medicaid recipients following the expiration of federal COVID-era waivers. Synthesizes epidemiological evidence showing telehealth reduces mortality by up to 56% for patients with chronic conditions in rural populations. Integrates federalism analysis, stakeholder mapping, and economic impact assessment to develop a policy recommendation for state-level Medicaid provisions addressing rural healthcare access for 34% of North Carolinians.

Policy Analysis Epidemiology Medicaid Rural Health

Full-Stack Optimization of a Multi-State Software System for Clinical Electroporation Devices

Bioelectricity Lab, NC State University • PI: Dr. Mike Sano • 2025–Present

Ongoing engineering research developing firmware and software for novel clinical electroporation devices. Resolved multithreading security vulnerabilities that could cause unexpected system behavior, implemented fail-safe emulator protocols, and redesigned separate clinician and researcher frontends — reducing clinician interaction from 12 clicks to 3 while adding safety bounds visualization and automated patient reporting.

C Python Embedded Systems UI/UX NIH/NCI Funded

Hormonal Effects on ACL Fibroblast Gene Expression in a Porcine In Vitro Model

Comparative Medicine Institute, NC State University • 2024 • Podium Presentation & 3rd Place Poster — CMI Annual Summit

Investigated the effects of estrogen and progesterone on anterior cruciate ligament fibroblast gene expression using a porcine in vitro model of pre-pubescent female development. Found that progesterone has a greater effect on proteoglycan expression in ACL fibroblasts than estrogen, and that TGF-β1 stimulation significantly upregulates ECM production. Motivated by the observed 3–8× higher ACL injury rate in skeletally immature adolescent female athletes compared to males. Supported by the Comparative Medicine Institute SIRI program.

Cell Culture RNA Isolation PCR SQL Women's Health